Resources Contact Us Home
Browse by: INVENTOR PATENT HOLDER PATENT NUMBER DATE
 
 
Inventor:
Johnson; Dale E.
Address:
Emeryville, CA
No. of patents:
6
Patents:












Patent Number Title Of Patent Date Issued
8017116 Chimeric and humanized antibodies to .alpha.5.beta.1 integrin that modulate angiogenesis September 13, 2011
The present invention provides chimeric and humanized antibodies that specifically recognize .alpha.5.beta.1 integrin, and methods for using the antibodies for reducing or inhibiting angiogenesis in a tissue. Also provided are methods of determining therapeutically acceptable doses of
7897148 Chimeric and humanized antibodies to .alpha.5.beta.1 integrin that modulate angiogenesis March 1, 2011
The present invention provides chimeric and humanized antibodies that specifically recognize .alpha.5.beta.1 integrin, and methods for using the antibodies for reducing or inhibiting angiogenesis in a tissue. Also provided are methods of determining therapeutically acceptable doses of
7879987 Chimeric and humanized antibodies to .alpha.5.beta.1 integrin that modulate angiogenesis February 1, 2011
The present invention provides chimeric and humanized antibodies that specifically recognize .alpha.5.beta.1 integrin, and methods for using the antibodies for reducing or inhibiting angiogenesis in a tissue. Also provided are methods of determining therapeutically acceptable doses of
7776585 Chimeric and humanized antibodies to .alpha.5.beta.1 integrin that modulate angiogenesis August 17, 2010
The present invention provides chimeric and humanized antibodies that specifically recognize .alpha.5.beta.1 integrin, and methods for using the antibodies for reducing or inhibiting angiogenesis in a tissue. Also provided are methods of determining therapeutically acceptable doses of
7285268 Chimeric and humanized antibodies to .alpha.5.beta.1 integrin that modulate angiogenesis October 23, 2007
The present invention provides chimeric and humanized antibodies that specifically recognize .alpha.5.beta.1 integrin, and methods for using the antibodies for reducing or inhibiting angiogenesis in a tissue. Also provided are methods of determining therapeutically acceptable doses of
7276589 Chimeric and humanized antibodies to .alpha.5.beta.1 integrin that modulate angiogenesis October 2, 2007
The present invention provides chimeric and humanized antibodies that specifically recognize .alpha.5.beta.1 integrin, and methods for using the antibodies for reducing or inhibiting angiogenesis in a tissue. Also provided are methods of determining therapeutically acceptable doses of










 
 
  Recently Added Patents
Managing delivery of application server content
Methods, systems, and products for searching interactive menu prompting systems
Domain isolation through virtual network machines
Connector with shielding device and method for manufacturing connector
Antenna device and wireless communication apparatus
Digital broadcasting transmission and reception system, and a signal processing method using turbo processing and turbo decoding
Method and apparatus of motion vector prediction with extended motion vector predictor
  Randomly Featured Patents
Transaction card
Acoustic communication and locating devices for underground mines
Cursor and display management system for multi-function control and display system
System for diagnosing anomalies or breakdowns in a plurality of types of electronic control systems installed in motor vehicles
(Jus press) clip-on dispensing adapter for a portable water cooler
Pressure switch for energy recovery ventilator
Polishing slurry and method for chemical-mechanical polishing
Packaging apparatus
Mobile communication system and wireless apparatus to be used for the same
Method of manufacturing a semiconductor memory device having a floating gate electrode composed of 2-10 silicon grains